Skip to content

Living Well With Advanced Breast Cancer

Living Well With Advanced Breast Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07227038
Enrollment
50
Registered
2025-11-12
Start date
2026-01-13
Completion date
2026-12-31
Last updated
2026-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Breast Carcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma

Brief summary

This study evaluates the use of supportive care in patients with advanced breast cancer to better understand what has helped them, what has been hard, and what kind of help they still need.

Detailed description

PRIMARY OBJECTIVES: I. Assess acceptability of current LWABC model. II. Conduct a comprehensive review of participants' medical history, treatment records, and demographic data. III. Explore differences in survivorship care engagement across four distinct cohorts. OUTLINE: This is an observational study. Participants complete a survey and a semi-structured interview on study.

Interventions

OTHERNon-Interventional Study

Non-interventional study

Sponsors

Ohio State University Comprehensive Cancer Center
Lead SponsorOTHER
Lilly Foundation
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* \* COHORT 1: * Diagnosis of stage 4 metastatic breast cancer within the past 5 years * Never been referred to the LWABC * Adults age ≥ 18 years * COHORT 2: * Diagnosis of stage 4 metastatic breast cancer within the past 5 years * Have cancelled an appointment with the LWABC * Adults age ≥ 18 years * COHORT 3: * Been seen in the Medical Oncology Clinic at Stephanie Spielman Comprehensive Breast Center (SSCBC) within the past 5 years * Completed an appointment with the LWABC * Adults age ≥ 18 years * COHORT 4: * Caregivers for ABC patients * Adults age ≥ 18 years

Exclusion criteria

* Patients who cannot provide own informed consent

Design outcomes

Primary

MeasureTime frameDescription
Acceptability of current LWABC (Living Well with Advanced Breast Cancer) modelUp to study completion, up to 1 dayWill utilize a thematic inductive analysis approach to compare and contrast themes across cohorts. Survey items will be summarized by cohort. Means, standard deviations, medians and ranges will be calculated for continuous variables and frequency, percents and 95% confidence intervals will be calculated for categorical variables.
Participant medical history, treatment records, and demographic dataUp to study completion, up to 1 dayWill utilize a thematic inductive analysis approach to compare and contrast themes across cohorts. Survey items including demographic information and disease characteristics will be summarized by cohort. Means, standard deviations, medians and ranges will be calculated for continuous variables and frequency, percents and 95% confidence intervals will be calculated for categorical variables.
Differences in survivorship care engagement across four distinct cohortsUp to study completion, up to 1 dayWill utilize a thematic inductive analysis approach to compare and contrast themes across cohorts. Themes will be compared across each cohort to identify survivorship care needs that will be translated into intervention components for the ABC survivorship program. Survey items will be summarized by cohort. Means, standard deviations, medians and ranges will be calculated for continuous variables and frequency, percents and 95% confidence intervals will be calculated for categorical variables.

Countries

United States

Contacts

CONTACTThe Ohio State University Comprehensive Cancer Center
OSUCCCClinicaltrials@osumc.edu800-293-5066
PRINCIPAL_INVESTIGATORAshley P Davenport, MD

Ohio State University Comprehensive Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026